Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT00543400 Completed - Clinical trials for Coronary Artery Disease (CAD)

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)

EMINENCE
Start date: September 2007
Phase: Phase 2
Study type: Interventional

The primary objective is to evaluate the safety and feasibility of using M118 as an anticoagulant in the target population of subjects with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). The secondary objectives are to evaluate the effect of M118 on procedural indices including procedure success, abrupt closure, post-procedure TIMI flow, and catheter thrombus. Substudy Primary Objective The primary objective of the substudy is to characterize the pharmacokinetic and pharmacodynamic profile of M118 among subjects with stable coronary artery disease undergoing elective PCI.

NCT ID: NCT00541203 Completed - Coronary Disease Clinical Trials

Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests

CT-MPACT
Start date: October 2007
Phase: N/A
Study type: Observational

Coronary CT angiography (CCTA) offers great promise as a risk stratification tool in patients with suspected CAD. It has been demonstrated in a multitude of accuracy studies to have a negative predictive value averaging over 95%. This leads to the hypothesis that a negative CCTA may preclude the need for invasive testing. The purpose of this randomized controlled study is to prospectively evaluate the role of CCTA on the management of patients with inconclusive or indeterminate stress test results.CCTA is able to provide not only information on presence and extent of coronary artery calcification, but detailed coronary anatomy as well. SPECIFIC AIM # 1: To evaluate the diagnostic and prognostic performance of CCTA in patients with equivocal / intermediate stress test results as compared to conventional invasive coronary angiography. SPECIFIC AIM # 2: To evaluate the utility of CCTA in prediction of major adverse cardiac events (MACE) compared to invasive coronary angiography at 30 days, 1 year, 3 years and 5 years.

NCT ID: NCT00540761 Enrolling by invitation - Clinical trials for Coronary Arteriosclerosis

Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique

Start date: July 25, 2007
Phase: N/A
Study type: Interventional

Atherosclerosis, a condition in which fatty deposits of plaque build up along the inner walls of arteries, is a condition that may increase the risk of having a heart attack. Previous studies have shown that the presence of a specific kind of plaque, known as vulnerable plaque, is often found in people who have had a heart attack. This study will use a new imaging technique called optical frequency domain imaging (OFDI) to examine the presence of vulnerable plaques in people with coronary artery disease.

NCT ID: NCT00540670 Completed - Clinical trials for Coronary Artery Disease

A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease

Start date: October 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of E5555 in Japanese subjects with coronary artery disease.

NCT ID: NCT00539604 Completed - Clinical trials for Coronary Heart Disease

Non Invasive Multicenter Italian Study for Coronary Artery Disease

Start date: July 2004
Phase: Phase 4
Study type: Interventional

To determine if 16-64 slice multidetector CT (MDCT) can replace the invasive procedure in patients scheduled for coronary angiography in order to exclude the presence of CAD

NCT ID: NCT00538460 Terminated - Coronary Disease Clinical Trials

Evaluate the Effectiveness and Cost of Stress Cardiac Magnetic Resonance Imaging (MRI) for Non-invasive Evaluation of Lesions Discovered on Computed Tomography Angiography (CCTA)

DSTAT
Start date: September 2007
Phase: N/A
Study type: Observational

This study is designed to evaluate the effectiveness and measurable cost impact of stress cardiac MRI for non-invasive evaluation of intermediate lesions discovered on CCTA in low-to-intermediate risk patients admitted to the ED with suspected ACS. Our primary objective is to determine if the strategy of CTA + stress CMR will reduce the length of time in the ED required to establish a definitive diagnosis, compared to CTA + stress MPI.

NCT ID: NCT00536965 Completed - Diabetes Mellitus Clinical Trials

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Start date: July 2007
Phase: N/A
Study type: Observational

A cholesterol/lipid profile screening project of high risk patients with hyperlipidaemia (secondary prevention) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is <100mg/dl for patients with high risk and <70mg/dl for patients at very high risk) are screened (office-based specialists). The doctors therapy decisions after the screening and possible reasons for these decisions will be documented. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.

NCT ID: NCT00536796 Completed - Diabetes Mellitus Clinical Trials

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Start date: September 2007
Phase: N/A
Study type: Observational

A cholesterol/lipid profile screening project of high risk patients with hyperlipidaemia (secondary prevention) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is <100mg/dl for patients with high risk and <70mg/dl for patients at very high risk) are screened (hospital-based specialists). The doctors therapy decisions after the screening and possible reasons for these decisions will be documented. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.

NCT ID: NCT00535405 Completed - Clinical trials for Hypercholesterolemia

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

Start date: November 2007
Phase: Phase 3
Study type: Interventional

A multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus atorvastatin in elderly patients with high cholesterol at high or moderately high risk for coronary heart disease.

NCT ID: NCT00534651 Completed - Clinical trials for Coronary Arteriosclerosis

Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease

Start date: November 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of orally given paracetamol on the vascular function and on 24-hour blood pressure in patients with coronary artery disease